Latest News and Press Releases

- Promising data presented at Society for Immunotherapy of Cancer 36th Annual Meeting (SITC) - Multi-functional agent targeting three innate immune checkpoint receptors  - Potential as monotherapy and...

- Strengthened management team headed by Jörg Neermann as CEO Goettingen, Germany, October 20, 2021 - Curexsys GmbH, a leader in the emerging field of therapeutic exosomes, today announced the...

- Preclinical data highlighting mode-of-action of lead program iosH2 Schlieren (Zurich Area), Switzerland. – October 13, 2021 – ImmunOs Therapeutics AG, a Swiss biotechnology company developing...

- Company prepares for further growth and entry into clinical development- Prof. Andrew Scott, Dmitriy Zamarin, MD, PhD, Prof. Dr. med. Dirk Jäger, and Jeffrey M. Bockman, PhD, appointed as clinical...

Dr. Weiss brings more than 15 years of experience in biomarker and in vitro diagnostics development Company launched targeted recruiting campaign for next phase of corporate life cycle Cologne,...

Dr. Weiss verfügt über mehr als 15 Jahre Erfahrung mit der Entwicklung von Biomarkern und In-vitro-Diagnostika Unternehmen hat gezielte Rekrutierungskampagne für die nächste Phase der...

- Seventure Partners and Novartis Pharmaceuticals join as new investors- Transformative treatment for millions of children with myopia Berlin, Germany, July 14, 2021 --- Dopavision, a company...

Company raises EUR 4 million to reach key value-creating milestones over the next 12-18 monthsKlaus Albrecht, Alluti GmbH, appointed as new member of the Supervisory Board Cologne, Germany, July...

Unternehmen wirbt EUR 4 Mio. zum Erreichen wichtiger wertsteigernder Meilensteine innerhalb der nächsten 12-18 Monate einKlaus Albrecht, Alluti GmbH, wird Mitglied des Aufsichtsrats Köln,...

MUNICH, Germany, July 7, 2021 – Eisbach Bio, a biotechnology company targeting the molecular machines that drive human disease, today announced additional financial support from the German Ministry...